Lineage Cell Therapeutics (LCTX) Earnings Prediction
Updated August 11, 2026 · AltIndex alt-data view going into the print
AltIndex AI Score on Lineage Cell Therapeutics is 51 — signals are mixed heading into the print. Underlying trend: 2 of 4 tracked signals trending down over the last 3 months.
LCTX stock price — last 3 months
Lineage Cell Therapeutics (LCTX) is trading at $1.13, down 11.7% over the last 3 months (from $1.28 three months ago).
What the alt-data signals say about Lineage Cell Therapeutics right now
Trends across the last 3 months — the run-up to Lineage Cell Therapeutics’s next earnings print.
| Signal | Current | 3-month change |
|---|---|---|
| Job postings | 1 | ↓ -50.0% |
| LinkedIn headcount | 34 | → -2.9% |
| Web traffic | 4,016 | ↓ -27.7% |
| X followers | 2,358 | → +0.2% |
Full daily-resolution trend charts on every signal are on the LCTX ticker page.
Get alerted when LCTX signals inflect
AltIndex stock alerts fire when alt-data on LCTX breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.
Sign up to AltIndex →Lineage Cell Therapeutics earnings: frequently asked questions
When does Lineage Cell Therapeutics report earnings next?
What does the AltIndex AI Score say about Lineage Cell Therapeutics going into earnings?
What is the EPS estimate for Lineage Cell Therapeutics?
How accurate are AltIndex’s earnings predictions for Lineage Cell Therapeutics?
Where can I see the full signal breakdown on Lineage Cell Therapeutics?
How can I get alerted before Lineage Cell Therapeutics reports earnings?
Other earnings predictions
Other companies in the AltIndex universe reporting earnings in the next 2 weeks, sorted by AI Score.
See every alt-data signal on LCTX
Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Lineage Cell Therapeutics — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.
Sign up to AltIndex → Log inAbout AltIndex
